BioWorld

Nov. 24, 2003

Stock Winners and Losers For The Week

Biotech - Big Pharma Collaborations:New Agreements, Sept. 25 - Nov. 20, 2003#

Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Sept. 25 - Nov. 20, 2003#

Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, Sept. 25 - Nov. 20, 2003#

BioWorld Stock Report For Public Biotechnology Companies

AMD Race: Eyetech Drug Falters, Challengers Will Face Visudyne

Age-related macular degeneration (AMD) is a demon of the elderly, snatching away their sight at a time in life when, for many, to watch the world is one of the great pleasures - a pleasure not afforded them in the busy, earlier years. Read More

Money Raised Year To Date

Today's news in brief

BioWorld

BioWorld briefs for April 17, 2026.

Man holding raised arm with illustrated overlay of nerves

Biohaven reports details on discovery of BHV-2100

BioWorld Science

Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...

New GABA(B) receptor PAMs revealed in Addex Pharma patents

BioWorld Science

Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...

Elderly woman holding illustration of brain with missing puzzle piece

Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

BioWorld

The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...

Novel caspase-2 inhibitor shows in vivo neuroprotective effects

BioWorld Science

Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...